Document Type : Original Article
Authors
1 Department of Pharmacoeconomics and Pharmaceutical Management, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Health Management and Economics, Tehran University of Medical Sciences, Tehran, Iran Knowledge Utilization Research Center, Tehran University of Medical Sciences, Tehran, Iran
3 Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland
Abstract
Objective: In the past decades economic sanctions have been used by different countries
or international organizations in order to deprive target countries of some transactions.
While the sanctions do not target health care systems or public health structures, they
may, in fact, affect the availability of health care in target countries. In this study, we used
media analysis to assess the impacts of recent sanctions imposed by the Central Bank of
Iran in 2012 on access to medicines in Iran.
Methods: We searched different sources of written news media including a database of
nonspecialized weeklies and magazines, online news sources, web pages of daily newspapers
and healthcare oriented weeklies from 2011 to 2013. We searched the sources using the
general term “medicine” to reduce the chances of missing relevant items. The identified news
media were read, and categorized under three groups of items announcing “shortage of
medicines,” “medicines related issues” and “no shortage.” We conducted trend analyzes to
see whether the news media related to access to medicines were affected by the economic
sanctions.
Findings: A total number of 371 relevant news media were collected. The number of news
media related to medicines substantially increased in the study period: 30 (8%), 161 (43%)
and 180 (49%) were published in 2011, 2012 and 2013, respectively. While 145 (39%) of
media items referred to the shortage of medicines, 97 (26%) reported no shortage or
alleviating of concerns.
Conclusion: Media analysis suggests a clear increase in the number of news media reporting
a shortage in Iran after the sanctions. In 2013, there were accompanying increases in the
number of news media reporting alleviation of the shortages of medicines. Our analysis
provides evidence of negative effects of the sanctions on access to medicines in Iran.
Keywords
- World Health Organization. MDG – Health and the
Millennium Development Goals. Geneva: World Health
Organization; 2005.
2. Methodology Report 2012 Stakeholder Review. Access to
Medicine Foundation; 2012.
3. AbdollahiasA, Nikfar S, Abdollahi M. Pharmaceutical market
and health system in the Middle Eastern and Central Asian
countries: Time for innovations and changes in policies and
actions. Arch Med Sci 2011;7:365‑7.
4. Lewis M, Verhoeven M. Financial Crises and Social Spending,
The Impact of the 2008‑2009 Crisis. Washington: World Bank;
2010.
5. CheraghaliAM. Impacts of international sanctions on Iranian
pharmaceutical market. Daru 2013;21:64.
6. RechelB, SuhrckeM, Tsolova S, Suk JE, DesaiM, McKeeM, et al.
Economic crisis and communicable disease control in Europe:
A scoping study among national experts. Health Policy
2011;103:168‑75.
7. Vandoros S, Stargardt T. Reforms in the Greek pharmaceutical
market during the financial crisis. Health Policy 2013;109:1‑6.
8. Kebriaeezadeh A, Koopaei NN, Abdollahiasl A, Nikfar S,
Mohamadi N. Trend analysis of the pharmaceutical market in
Iran; 1997‑2010; policy implications for developing countries.
Daru 2013;21:52.
9. Mohammadi D. US‑led economic sanctions strangle Iran’s
drug supply. Lancet 2013;381:279.
10. Namazi S. Sanctions and Medical Supply Shortages in Iran.
Viewpoints No. 20. Dubai: Woodrow Wilson Center; 2013. - 11. Golzari S, Ghabili K, Mohammad Khanli H, Tizro P,
Rikhtegar R. Access to cancer medicine in Iran. Lancet
2013;381:279.
12. Wolfensohn J. The Right to Tell: The Role of Mass Media
in Economic Development. World Bank Institute Report.
Washington: World Bank; 2002.
13. Chakravartty P, Dowing J. Media, technology, and the global
financial crisis. Int J Commun 2010;4:693‑5.
14. Butler D. Iran hit by drug shortage. Nature 2013;504:15‑6.
15. Kamali Dehghan S. Iran Sanctions ‘Putting Millions of Lives
at Risk. The Guardian Daily; 17 October, 2012.
16. Jönsson AM. Framing environmental risks in the Baltic Sea:
A news media analysis. Ambio 2011;40:121‑32.
17. The Impact of Sanctions on the Iranian People’s Healthcare
System. Ver. 1.1. Geneva: International Institute for Peace,
Justice and Human Rights; 2013.
18. Bossuyt M. The Adverse Consequences of Economic Sanctions.
Economic and Social Council 21 June 2000; E/CN.4/Sub. 2//33.
Geneva: Commission on Human Rights; 2000.
19. Karanikolos M, Mladovsky P, Cylus J, Thomson S, Basu S,
Stuckler D, et al. Financial crisis, austerity, and health in Europe.
Lancet 2013;381:1323‑31.
20. Kastanioti C, Kontodimopoulos N, Stasinopoulos D,
Kapetaneas N, Polyzos N. Public procurement of health
technologies in Greece in an era of economic crisis. Health
Policy 2013;109:7‑13.
21. Buysse IM, Laing RO, Mantel AK. Impact of the economic
recession on the pharmaceutical sector. Utrecht: Utrecht
University; 2010.
22. Kheirandish M, Rashidian A, Kebriaeezade A, Cheraghali AM,
Soleymani F, A review of pharmaceutical policies in response
to economic crises and sanctions. J Res Pharm Pract
2015;4:115-22.
23. Hosseini SA. Impact of sanctions on procurement of medicine
and medical devices in Iran; a technical response. Arch Iran
Med 2013;16:736‑8.
24. Behmane D, Innus J. Pharmaceutical policy and the effects of
the economic crisis: Latvia. Eurohealth 2011;4:69‑79.
)